Annual return of 118.79% - See How Click here now!
FinancialBusinessNews is part of Stock Profiler.US, LLC's News Division. Stock Profiler welcomes investors to chat LIVE about these stocks and more on their upgraded website with FREE Investor Tools, Live Chats, and much more! Sign up now at www.stockprofiler.us. Companies who want to broadcast their message are encouraged to contact Stock Profiler.US, LLC at (603) 424-4420.
-------------------------------------------
Union Pacific Corporation (NYSE: UNP | Quote | Chart | News | PowerRating) closed at $69.15 Monday, trading 7,933,000 shares.
Company News- September 30, 2008: Michael R. McCarthy Elected to Union Pacific Corporation Board of Directors
Union Pacific Corporation (NYSE: UNP | Quote | Chart | News | PowerRating) announced earlier today that Michael R. McCarthy, 57, has been elected to the company's board of directors, effective October 1, 2008. Mr. McCarthy serves as chairman of McCarthy Group, LLC, an Omaha-based investment firm he co-founded in 1986. He is responsible for the management of McCarthy Group and is chairman of the company's underwriting committee. He also is a director of Peter Kiewit Sons', Inc., Cabela's Incorporated and several portfolio companies affiliated with McCarthy Group's private equity business.
To read the full news release, go to www.stockprofiler.us, and click the Headline link after entering the ticker symbol.
About Union Pacific
Union Pacific Corporation owns one of America's leading transportation companies. Its principal operating company, Union Pacific Railroad, links 23 states in the western two-thirds of the country and serves the fastest-growing U.S. population centers. Union Pacific's diversified business mix includes Agricultural Products, Automotive, Chemicals, Energy, Industrial Products and Intermodal. The railroad offers competitive long-haul routes from all major West Coast and Gulf Coast ports to eastern gateways. Union Pacific connects with Canada's rail systems and is the only railroad serving all six major gateways to Mexico, making it North America's premier rail franchise.
-------------------------------------------
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA | Quote | Chart | News | PowerRating) closed at $13.84 Monday, trading 103,200 shares.
Company News- September 30, 2008: Idera Pharmaceuticals to Present at JMP Securities Healthcare Focus Conference
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biopharmaceutical company focused on developing therapeutics targeting Toll-Like Receptors (TLR), announced earlier today that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at The Third Annual JMP Securities Healthcare Focus Conference on Monday, October 6, 2008 at 9:00 a.m. (ET) at Le Parker Meridien Hotel in New York City.
To read the full news release, go to www.stockprofiler.us, and click the Headline link after entering the ticker symbol.
About Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals develops drug candidates to treat infectious diseases, autoimmune diseases, cancer, and respiratory diseases, and for use as vaccine adjuvants. Our proprietary drug candidates are designed to modulate specific Toll-like Receptors, which are a family of immune system receptors that direct immune system responses. Our pioneering DNA and RNA chemistry expertise enables us to create drug candidates for internal development and generates opportunities for multiple collaborative alliances. For more information, visit www.iderapharma.com.
-------------------------------------------
The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. FinancialBusinessNews.US is a division of Stock Profiler.US, LLC's News Division, which includes but is not limited to www.stockprofiler.us, www.associatesfortune.com, www.businessnetwire.us, www.fastmoneytalk.com, www.markettelegraph.com, www.thewallstreetleader.com and www.daytradersdigest.com. Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.
Please consult a broker before purchasing or selling any securities mentioned herein. To view full disclaimers and terms of use, go to www.stockprofiler.us.
Keywords: Small Cap Investments, Investor Relations, I/R Services, Investment Tools, Stock Profiles, Stock Market Quotes News, Media Coverage
CONTACT: Financialbussinessnews.US Tel: +1 603 424 4420 e-mail: info@stockprofiler.us WWW: http://www.financialbusinessnews.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
